Top Sens. Target Drug Cos.' Pay-For-Delay Deals
Two influential U.S. senators have introduced legislation that would outlaw what they call anti-competitive payments made by brand-name pharmaceutical companies to generics makers that resolve patent fights by delaying the availability...To view the full article, register now.
Already a subscriber? Click here to view full article